Forecast & Rating3 analysts currently cover Mesoblast, of which 3 give a positive rating. The average price target is $37.00, about 121.3% upside from the current price of $16.72. Coverage is limited, so the data is for reference only. Data as of Aug 28, 2026; this does not constitute investment advice.
Aug 28, 2026Price forecast
$37.00121.56%
Forecast & RatingBuy
3analysts
- Strong buy33.33%
- Buy66.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 30, 2026
Forecast met20.7%
Stock price$16.72
Avg. target$35.0
High target$35
Low target$35
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.